Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Why D-Wave Quantum Stock Is Soaring Today (Fool) +++ D-WAVE Aktie +4,53%

BIO-TECHNE Aktie

 >BIO-TECHNE Aktienkurs 
47.4 EUR    +4.9%    (Tradegate)
Ask: 47 EUR / 71 Stück
Bid: 46.8 EUR / 71 Stück
Tagesumsatz: 10 Stück
Realtime Kurs von 8 bis 22 Uhr!
BIO-TECHNE Aktie über LYNX handeln
>BIO-TECHNE Performance
1 Woche: +6,3%
1 Monat: +11,8%
3 Monate: +0,4%
6 Monate: -35,7%
1 Jahr: -33,2%
laufendes Jahr: -31,8%
>BIO-TECHNE Aktie
Name:  BIO-TECHNE CORP. DL-,01
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US09073M1045 / A12ENG
Symbol/ Ticker:  TE1 (Frankfurt) / TECH (NASDAQ)
Kürzel:  FRA:TE1, ETR:TE1, TE1:GR, NASDAQ:TECH
Index:  S&P500
Webseite:  https://www.bio-techne.co..
Marktkapitalisierung:  7102.45 Mio. EUR
Umsatz:  1030.95 Mio. EUR
EBITDA:  344.2 Mio. EUR
Gewinn je Aktie:  0.71 EUR
Schulden:  361.2 Mio. EUR
Liquide Mittel:  119.98 Mio. EUR
Umsatz-/ Gewinnwachstum:  4.44% / -35.31%
KGV/ KGV lG:  59.34 / 27.92
KUV/ KBV/ PEG:  6.98 / 3.78 / 1.33
Gewinnm./ Eigenkapitalr.:  10.89% / 6.53%
Dividende je Aktie:  0.29 EUR
Dividendenrendite/ -schätzung:  0.6% / 0.6%
Div. Historie:  19.05.25 - 0.07166€
14.02.25 - 0.07644€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  BIO-TECHNE, BIO TECHNE
Letzte Datenerhebung:  23.07.25
>BIO-TECHNE Eigentümer
Aktien: 156.77 Mio. St.
f.h. Aktien: 154.95 Mio. St.
Insider Eigner: 1.06%
Instit. Eigner: 105.62%
>BIO-TECHNE Peer Group

 
18.07.25 - 07:06
Bio-Techne′s Quarterly Earnings Preview: What You Need to Know (Barchart)
 
Bio-Techne is expected to report its fiscal fourth-quarter earnings next month, and analysts forecast a modest single-digit decrease in its bottom line....
17.07.25 - 13:01
Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results (PR Newswire)
 
MINNEAPOLIS, July 17, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, August 6, 2025, at 8:00 a.m. CDT to review its fourth quarter and fiscal 2025 financial results. Access to the discussion......
16.07.25 - 00:48
Spear Bio Partners With Bio-Techne To Expand Access To UltraSensitive Neuro Biomarker Assays (AFX)
 
WASHINGTON (dpa-AFX) - Spear Bio has entered a strategic global distribution agreement with Bio-Techne (TECH) to broaden access to its SPEAR UltraDetectT immunoassays, beginning with applications ......
15.07.25 - 13:01
Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection (PR Newswire)
 
MINNEAPOLIS, July 15, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced a strategic partnership to distribute Spear Bio's next-generation ultrasensitive immunoassays, enabling the detection of low-abundance biomarkers in neurology. Under the agreement, Bio-Techne......
14.07.25 - 13:03
Bio-Techne′s Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene Therapy (PR Newswire)
 
MINNEAPOLIS, July 14, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that its Simple Western™ Technology played a key role in supporting the FDA approval of ZEVASKYN™ (prademagene zamikeracel), the first autologous cell-based gene therapy for patients with......
09.07.25 - 17:06
Bio-Techne a new buy at TD Cowen on organic growth potential (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
04.07.25 - 12:15
Bio-Techne: Innovation, Expansion und ein möglicher Kursausbruch (LYNX)
 
Bio-Techne könnte vor einem Wachstumsschub stehen. Bisher wird das nicht nur ignoriert, sondern mit einem Kurssturz quittiert....
25.06.25 - 14:54
Is Bio-Techne Stock Underperforming the Nasdaq? (Barchart)
 
Bio-Techne has underperformed the Nasdaq over the past year, but analysts are moderately optimistic about the stock's prospects....
25.06.25 - 05:01
Bio-Techne Partners With USP To Distribute MAb And AAV Standards For Biotherapeutic Development (AFX)
 
WASHINGTON (dpa-AFX) - Bio-Techne Corporation (TECH) has entered a distribution agreement with the U.S. Pharmacopeia - USP, allowing it to sell USP monoclonal antibody - mAb and adeno-associated v......
24.06.25 - 13:39
Bio-Techne and USP to accelerate monoclonal antibody and gene therapy product development (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
24.06.25 - 13:03
Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development (PR Newswire)
 
MINNEAPOLIS, June 24, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced a distribution agreement with the U.S. Pharmacopeia (USP) that enables the Company to sell USP monoclonal antibody (mAb) and recombinant adeno-associated virus (AAV) reference standards with......
12.06.25 - 02:01
Insiderhandel: Aufsichtsrat verkauft Aktien von Bio-Techne im Wert von 63705 USD (Insiderkauf)
 
Herr, Amy E. - Aufsichtsrat - Tag der Transaktion: 2025-06-09...
10.06.25 - 13:01
ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics (PR Newswire)
 
ST. PAUL, Minn., June 10, 2025 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that Immuneel Therapeutics has been awarded a $150,000 G-Rex® Grant to support process development aimed at enhancing the......
29.05.25 - 13:01
Bio-Techne to Present at Investor Conferences (PR Newswire)
 
MINNEAPOLIS, May 29, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences: William Blair 45th Annual Growth Stock Conference June 3, 2025 2:40 PM CDT Jefferies Global Healthcare Conference June 4, 2025 3:45......
19.05.25 - 09:36
Do Wall Street Analysts Like Bio-Techne Stock? (Barchart)
 
Bio-Techne has notably underperformed the broader market over the past year, and analysts remain cautiously optimistic about the stock's prospects....
14.05.25 - 13:00
ScaleReady awards multiple G-Rex® Grants to leading investigators at the University of Southern California (USC) and the Children′s Hospital of Los Angeles (CHLA) (PR Newswire)
 
ST. PAUL, Minn., May 14, 2025 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady announced today three G-Rex Grants that have been awarded to faculty members at the University of Southern California (USC) and......
12.05.25 - 13:01
Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025 (PR Newswire)
 
MINNEAPOLIS, May 12, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its latest spatial biology and cell and gene therapy workflow solutions at the American Society of Gene & Cell Therapy (ASGCT) 2025 meeting taking place in New Orleans between......
08.05.25 - 15:33
Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing (PR Newswire)
 
Kytopen and Bio-Techne announce partnership on an integrated cellular engineering workflow to expedite cell therapy manufacturing. The TcBuster™ system offers a fast and scalable method to integrate large, multigene cargos with high editing efficiency in a single vector, while Flowfect®......
07.05.25 - 17:15
Bio-Techne Q3 Earnings & Revenues Top Estimates, Stock Up in Premarket (Zacks)
 
TECH registers continued growth momentum across its Diagnostics & Spatial Biology segment in third-quarter fiscal 2025....
07.05.25 - 16:48
Bio-Techne outlines 2025 growth drivers with NIH uncertainty and strong Protein Sciences performance (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Unzufriedenheit ist die erste Stufe zum Fortschritt für den einzelnen wie für die Nation. - Oscar Wilde
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!